From:
`To:
`Cc:
`Subject:
`Date:
`
`Trials
`Sodikoff, Brian; Trials
`Ferenc, Christopher B.; Sommers, Erin; Feldstein, Mark; DeRoo, Pier; McCurdy, Barbara
`RE: IPR2019-00789 Sawai v. Biogen
`Monday, June 3, 2019 3:23:55 PM
`
`EXTERNAL Email:
`
`Counsel,
` 
`The panel declines Petitioner’s request to limit the scope of Patent Owner Preliminary Response.  Patent
`Owner may address RPI in its Preliminary Response.  Petitioner may request authorization to file a reply
`to the Patent Owner Preliminary Response, if it so desires.  The panel also notes that no right to cross-
`examination has been waived at this preliminary stage of the proceeding, but that cross-examination
`during the preliminary stages of a proceeding is not typically available, absent authorization from the
`Board.  We have not authorized any cross-examination at this time.  The panel believes that our guidance
`here addresses sufficiently the current dispute between the parties and, as such, a teleconference is not
`needed at this time. 
` 
` 
`Regards,
` 
`Andrew Kellogg,
`Supervisory Paralegal
`Patent Trial and Appeal Board
`USPTO
`andrew.kellogg@uspto.gov
`Direct: 571-272-5366
` 
` 
` 
`From: Sodikoff, Brian <brian.sodikoff@kattenlaw.com>
`Sent: Friday, May 31, 2019 3:34 PM
`To: Trials <Trials@USPTO.GOV>
`Cc: Ferenc, Christopher B. <christopher.ferenc@kattenlaw.com>; Sommers, Erin
`<Erin.Sommers@finnegan.com>; Feldstein, Mark <mark.feldstein@finnegan.com>; DeRoo, Pier
`<Pier.DeRoo@finnegan.com>; McCurdy, Barbara <barbara.mccurdy@finnegan.com>
`Subject: IPR2019-00789 Sawai v. Biogen
`
`To the Honorable Board:
`
`Petitioners Sawai USA, Inc. and Sawai Pharmaceuticals, Ltd. (together “Sawai”) respectfully
`request a telephone conference with the Board to determine whether briefing on the RPI
`issue, first raised in Patent Owner’s opposition to Sawai’s Motion for Joinder, is closed in view
`of the Sur-reply filed by Patent Owner on May 21, 2019. Sawai contends that briefing on the
`RPI issue is now closed in view of the Board’s previous ruling (Paper No. 12). Patent Owner
`contends that Sawai has mischaracterized the Board’s Order, and plans to further brief the RPI
`issue in its POPR. The parties met and conferred on May 29, 2019 to discuss this issue and
`were unable to resolve their dispute.
`
`Biogen Exhibit 2006
`Sawai v. Biogen
`IPR2019-00789
`
`Page 1 of 2
`
`

`

`Patent Owner Biogen understands Sawai’s position to be that (1) “Biogen waived any right it
`had to seek cross-examination of [Sawai’s RPI declarant] Mr. Hiramatsu” though without any
`statute, rule, or precedent to support its position; (2) Biogen is not entitled to address RPI in
`its POPR, again without any authority in support, and (3) RPI should “be resolved by the Board
`in deciding Sawai’s Motion for Joinder,” also without any supporting authority. Biogen
`disagrees with Sawai’s positions, and notes further that Sawai’s actions--seeking additional
`hearings with the Board without basis in the PTAB’s rules--further demonstrates the problems
`of potential joinder with a party that, like Sawai, has created RPI disputes and is taking an
`active rather than a bystander role.
`
`Sawai and Patent Owner are generally available June 3, 4, 5 (before noon), 6 (before noon),
`and 11 for a conference with the Board.
`
`Respectfully,
`
`Brian Sodikoff
`Counsel for Sawai
`
`Brian Sodikoff
`Partner
`Katten Muchin Rosenman LLP
`525 W. Monroe Street / Chicago, IL 60661-3693
`p / +1.312.902.5462 f / +1.312.902.1061
`brian.sodikoff@kattenlaw.com / www.kattenlaw.com
`===========================================================
`CONFIDENTIALITY NOTICE:
`This electronic mail message and any attached files contain information
`intended for the exclusive
`use of the individual or entity to whom it is addressed and may contain
`information that is
`proprietary, privileged, confidential and/or exempt from disclosure under
`applicable law. If you
`are not the intended recipient, you are hereby notified that any viewing,
`copying, disclosure or
`distribution of this information may be subject to legal restriction or
`sanction. Please notify
`the sender, by electronic mail or telephone, of any unintended recipients and
`delete the original
`message without making any copies.
`===========================================================
`NOTIFICATION: Katten Muchin Rosenman LLP is an Illinois limited liability
`partnership that has
`elected to be governed by the Illinois Uniform Partnership Act (1997).
`===========================================================
` 
`
`Page 2 of 2
`
`Page 2 of 2
`
`